This may be due to AML cells being less sensitive to calicheamicin, higher levels of CD33 on leukemic blasts, higher levels of CD33 saturation, and a continuous loop of internalization and renewed expression of CD33 antigens might be required for a sufficient accumulation of calicheamicin inside AML cells; whereas in ALL cells lower levels of accumulated calicheamicin might be sufficient to cause apoptosis [9]. Here, CD33 is linked to acute lymphoblastic leukemia.